Aimee Picchi is the associate managing editor for CBS MoneyWatch, where she covers business and personal finance. She previously worked at Bloomberg News and has written for national news outlets ...

GLP-1, an incretin hormone secreted by intestinal L ... These drugs have a clear antiatherosclerotic effect and a positive impact on postprandial lipid metabolism, helping to reduce the burden ...

Department of Cardiology, Rigshospitalet, Copenhagen, Denmark (T.D., K.R., M.E., W.H.N., F.G.). Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty ...

Glucagon-like peptide 1 (GLP-1) receptor agonists have transformed the treatment of type 2 diabetes and obesity since the FDA approval of Byetta (exenatide ... it’s important to understand that these ...

Walmart and Target have each issued statements about rising prices on groceries and general merchandise if tariffs take effect, with reports claiming Walmart is already pushing Chinese suppliers ...

Millions of workers will receive a pay rise after the statutory minimum rate increased on Tuesday in a move unions believe will help boost economic growth. However, business groups have cautioned ...

Glucagon-like peptide 1 receptor agonists (GLP1-RAs) are incretin-based glucose-lowering medications commonly used in the management of type 2 diabetes and obesity. They function by mimicking the ...

Five risk factors account for approximately 50% of the global burden of cardiovascular disease. How the presence or absence of classic risk factors affects lifetime estimates of cardiovascular ...

Charles revealed that he’d also experienced this same side effect to his own cancer treatment. Buckingham Palace have still not confirmed the details of his treatment or disclosed the form of ...

Stanford researchers have discovered a naturally occurring molecule, BRP, that reduces appetite and body weight in animals similarly to semaglutide (Ozempic) but without its common side effects like .

Americans can expect new vehicles to have higher sticker prices due to a new tariff on auto imports by the Trump administration.